Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2005
07/21/2005US20050159437 Pharmaceutical agents
07/21/2005US20050159434 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents
07/21/2005US20050159426 Novartis drug called Imatinib, 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide, methanosulfonate; synergistic mixture with a second antineoplastic agent
07/21/2005US20050159421 Ethylene diamine derivatives and their use as orexin-receptor antagonists
07/21/2005US20050159418 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders
07/21/2005US20050159409 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence
07/21/2005US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
07/21/2005US20050159397 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent
07/21/2005US20050159359 Methods and compositions for derepression of IAP-inhibited caspase
07/21/2005US20050159336 Administering activated lymphocytes; promote nerve regeneration
07/21/2005US20050158784 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
07/21/2005US20050158724 Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
07/21/2005US20050158406 Methods for treating joint inflammation
07/21/2005US20050158380 Sustained release oral dosage forms of gabapentin
07/21/2005US20050158348 Eutectic mixture of camphor, menthol, thymol and similar compounds is a powerful solvent for non-steroidal anti-inflammatory drugs; transdermal drug delivery of e.g. indomethacin, diclofenac, or ketoprofen
07/21/2005US20050158288 Methods of organ regeneration
07/21/2005US20050158264 Sympathetic nerve-stimulating fragrant compositions
07/21/2005DE19901683B4 Analgetikum mit kontrollierter Wirkstofffreisetzung Analgesic with controlled release of active ingredient
07/21/2005CA2678165A1 Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride
07/21/2005CA2678125A1 Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride
07/21/2005CA2678124A1 Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride
07/21/2005CA2592867A1 Treatment
07/21/2005CA2552946A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/21/2005CA2552851A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
07/21/2005CA2552850A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/21/2005CA2552221A1 Donepezil formulations
07/21/2005CA2552126A1 Ziprasidone formulations
07/21/2005CA2552114A1 Solid dosage formulations of galantamine
07/21/2005CA2552098A1 Benzo[d]isoxazol-3-ol daao inhibitors
07/21/2005CA2551952A1 Pyrrole and pyrazole daao inhibitors
07/21/2005CA2551862A1 Piperazines useful for treating pain
07/21/2005CA2551523A1 Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever
07/21/2005CA2551346A1 N-substituted piperidine and piperazine derivatives
07/21/2005CA2549979A1 3-quinuclidinyl heteroatom bridged biaryl derivatives
07/21/2005CA2549976A1 3-quinuclidinyl amino-substituted biaryl derivatives
07/21/2005CA2549962A1 Spirocyclic quinuclidinic ether derivatives
07/21/2005CA2549330A1 Calcitonin gene related peptide receptor antagonists
07/21/2005CA2548039A1 5-fluoro-, chloro- and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5
07/20/2005EP1555265A1 7-phenyl pyrazolopyridine compounds
07/20/2005EP1555263A1 Process for producing paroxetine hydrochloride hydrate
07/20/2005EP1555025A2 Use of dehydroepiandrosterone analogs for the treatment of asthma
07/20/2005EP1555022A1 Sustained release compound of acetamidophenol and tramadol
07/20/2005EP1554936A1 Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain
07/20/2005EP1554572A2 Compositions and methods for modulating blood-brain barrier transport
07/20/2005EP1554311A2 Humanized antibodies that recognize beta amyloid peptide
07/20/2005EP1554305A1 Prion protein-binding peptide sequences
07/20/2005EP1554286A1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
07/20/2005EP1554282A2 Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof
07/20/2005EP1554280A2 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors
07/20/2005EP1554275A2 Compounds
07/20/2005EP1554270A2 Isolation, purification and synthesis of procyanidin b2 and uses thereof
07/20/2005EP1554268A1 Pyrazole inhibitors of the transforming growth factor
07/20/2005EP1554262A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
07/20/2005EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands
07/20/2005EP1554258A1 5-substituted-2-arylpyrazines as modulators of crf receptors
07/20/2005EP1554256A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
07/20/2005EP1554254A1 Novel compounds
07/20/2005EP1554253A1 Imidazolium cxcr3 inhibitors
07/20/2005EP1554250A1 Novel lactams and uses thereof
07/20/2005EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
07/20/2005EP1554244A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
07/20/2005EP1554243A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
07/20/2005EP1553961A1 Use of enteric glia to promote functional nerve connections
07/20/2005EP1553952A1 Use of dihydroimidazolones for the treatment of epilepsy in dogs
07/20/2005EP1553942A1 Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
07/20/2005EP1553934A1 Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors
07/20/2005EP1553932A2 Derivatives of n-phenylanthranilic acid and 2-benzimidazolon as potassium channel and/or cortical neuron activity modulators
07/20/2005EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor
07/20/2005EP1553909A2 Quick dissolve compositions and tablets based thereon
07/20/2005EP1472251B1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
07/20/2005EP1392670B1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
07/20/2005EP1381606B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
07/20/2005EP1379511B1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
07/20/2005EP1303512B1 Process for preparing arylacetylaminothiazoles
07/20/2005EP1284959B1 Compounds for modulating the rage receptor
07/20/2005EP1272484B1 Benzoamide piperidine compounds as substance p antagonists
07/20/2005EP1268396B1 Diphenyl ether compounds useful in therapy
07/20/2005EP1263774B1 Gamma-secretase inhibitors
07/20/2005EP1261328B1 Il-8 receptor antagonists
07/20/2005EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
07/20/2005EP1241254B1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same
07/20/2005EP1198570B1 Monomeric protein of the tgf-beta family
07/20/2005EP1189583B1 Indole derivatives
07/20/2005EP1175401B1 Piperazine derivatives useful as ccr5 antagonists
07/20/2005EP1169052B1 Vegf angiogenic growth factors for treatment of peripheral neuropathy
07/20/2005EP1129077B9 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors
07/20/2005EP0828851B1 Tripeptidylpeptidase inhibitors
07/20/2005EP0703785B1 Methods for treating muscle diseases and disorders
07/20/2005CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system
07/20/2005CN1643137A Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
07/20/2005CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
07/20/2005CN1642983A Antibodies against of C5aR and use thereof
07/20/2005CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof
07/20/2005CN1642979A VEGF peptides and their use
07/20/2005CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof
07/20/2005CN1642961A Aminomethyl-substituted thiazolobenzimidazole derivative
07/20/2005CN1642960A Substituted amino isoxazoline derivatives and their use as anti-depressants
07/20/2005CN1642955A Novel alkoxypyridine-derivatives
07/20/2005CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
1 ... 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 ... 1833